Recombinant Anti-ADCYAP1R1 (ECD domain) Neutralizing Antibody (V3S-0622-YC10) (CAT#: V3S-0622-YC10)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Sub Cat Target Species Isotype Application Affinity  
V3S-1124-YC632 Human IgG2 kappa Block; FuncS 0.057 nM Inquiry
V3S-0622-YC11 Human IgG2 kappa Block; FuncS 0.024 nM Inquiry
Summary
Property
Applications
Protocols
Target

Summary

Description The anti-ADCYAP1R1 antibody was generated by immunizing with the ADCYAP1R1 (also known as PAC1) extracellular domain protein. The antibody binds to human and cynomolgus PAC1 and can inhibit binding of PAC1 to PACAP.
Clonality Monoclonal
Host Species Human
Target Species Human
Epitope The epitope is located in the extracellular domain.
Affinity KD = 0.057 nM
Isotype IgG2 kappa

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application Block; FuncS
Application Notes The antibody is recommended for detection of ADCYAP1R1 by Block, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target ADCYAP1R1
Alternative Name PAC1; PAC1R; PACAPR; PACAPRI; pituitary adenylate cyclase-activating polypeptide type I receptor; PACAP receptor 1; PACAP type I receptor; PACAP-R1; adenylate cyclase; activating polypeptide 1 (pituitary) receptor type I; pituitary adenylate cyclase activating polypeptide 1 receptor type I Hiphop; pituitary adenylate cyclase-activating; polypeptide type 1 receptor
Gene ID 117
UniProt P41586
Research Area Neuroscience; Signal Pathway
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry